Cognito Therapeutics today announced the appointment of four new executives to accelerate its growth and commercialization ...

View the full release here: "As Cognito nears completion of enrollment in our pivotal HOPE trial and prepares for regulatory ...

Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, today announced ...